Follistatin-344

A myostatin-binding protein variant studied in gene therapy research for muscular dystrophy.

What research shows

Follistatin's myostatin-binding role is well established in the literature, and follistatin gene therapy appears in reviews of muscular dystrophy and sarcopenia research. What we verified is review-level evidence. No trial of injectable follistatin protein in healthy people was found in the literature searched.

Evidence strength

Highest evidence grade among the graded claims: C. Grades reflect study strength, not benefit.

Safety context

See the safety section. Absence of a flag is not evidence of safety.

No endorsement

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.